arrow
H

Hideki Goto

Hokkaido University Hospital
H指数:21
被引数:1,524

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of lisocabtagene maraleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: 31-month follow-up of the phase 2 TRANSCEND FL study

来那度胺联合利妥昔单抗治疗复发或难治性滤泡性淋巴瘤的疗效与安全性:TRANSCEND FL研究31个月随访结果

2026-10-140
OAAI
Health-related quality of life with mosunetuzumab plus polatuzumab vedotin in R/R LBCL: Phase 3 SUNMO trial

mosunetuzumab联合polatuzumab vedotin在R/R LBCL中的健康相关生活质量:III期SUNMO试验

2026-10-120
OAAI
A multi-center, single-arm, phase 2 trial of dasatinib in T follicular helper cell lymphomas

多中心、单臂、II期临床试验:达沙替尼在T滤泡辅助细胞淋巴瘤中的应用

2026-10-050
OAAI
Real-world outcomes of tisagenlecleucel treatment in patients with relapsed or refractory large B-cell lymphomas: A nationwide registry

复发或难治性大B细胞淋巴瘤患者tisagenlecleucel治疗的实际世界结果:一项全国性登记研究

2025-12-240
PRE
Preliminary analysis of a multicenter study of Pola-R-CHP in untreated Japanese patients with DLBCL (POLASTAR)

POLASTAR研究:Pola-R-CHP在未经治疗的日本DLBCL患者中的多中心初步分析

2025-12-010
OA
Safety and efficacy of GVHD prophylaxis with mini-dose methotrexate in umbilical cord blood transplantation – NJHSG-CBT18 observational study –

GVHD预防中使用小剂量甲氨蝶呤在脐带血移植中的安全性与有效性——NJHSG-CBT18观察性研究

2025-11-060
PRE
Impact of single dose of pegfilgrastim on peripheral blood stem cell harvest in patients with multiple myeloma or malignant lymphoma

单次注射pegfilgrastim对多发性骨髓瘤或恶性淋巴瘤患者外周血干细胞采集的影响

2025-04-250
OA
Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes

POLARIX研究中使用临床医生和患者报告结局对周围神经病变的分析

2025-03-170
OA
Center effect on outcomes of second allogeneic hematopoietic stem cell transplantation for B-cell acute lymphoblastic leukemia: a nationwide retrospective study

中心效应对B细胞急性淋巴细胞白血病二次异基因造血干细胞移植结局的影响:一项全国性回顾性研究

2025-03-120
PRE
A phase II study of zandelisib in patients with relapsed or refractory indolent non-Hodgkin lymphoma: ME-401-K02 study

一项关于zandelisib在复发或难治性惰性非霍奇金淋巴瘤患者中的II期研究:ME-401-K02研究

2025-01-080
OAAI
Comparison of Clinical Characteristics and Prognosis between Aggressive NK-Cell Leukemia and Advanced-Stage Extranodal NK/T-Cell Lymphoma

比较侵袭性NK细胞白血病与晚期结外NK/T细胞淋巴瘤的临床特征及预后

BLOOD
IF23.1
2024-11-050
PRE
Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory (R/R) Follicular Lymphoma (FL): Transcend FL 2-Year Follow-up

利索卡巴肽马瑞克塞尔(liso-cel)在复发或难治性(R/R)滤泡性淋巴瘤(FL)患者(pts)中的2年随访:超越FL研究

BLOOD
IF23.1
2024-11-050
PRE
Reduced FDG Uptake in the Brain on Baseline 18FDG PET/CT Predicts Worse Prognosis of Newly Diagnosed Intravascular Large B-Cell Lymphoma and Advanced-Stage Diffuse Large B-Cell Lymphoma

基线18FDG PET/CT上脑部FDG摄取降低预测新诊断的血管内大B细胞淋巴瘤和晚期弥漫性大B细胞淋巴瘤的不良预后

BLOOD
IF23.1
2024-11-050
PRE